Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
KelSie Biotech
AddedFeb 16, 2024
UpdatedJun 18, 2026
KelSie Biotech

KelSie Biotech

KelSie Biotech develops high bioavailability delivery methods, including dry powder inhalable products for easy dosage.

HQ
Englewood, CO, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

KelSie Biotech, founded with a mission to revolutionize drug delivery systems, focuses on developing high bioavailability methods for sensitive Active Pharmaceutical Ingredients (APIs). The company specializes in creating dry powder inhalable products using its patented Carbon-Dioxide Assisted Nebulization Bubble Drying (CAN-BD) process, as well as sublingual wafers. These innovations aim to make daily dosages more accessible and effective for patients, positioning KelSie Biotech at the forefront of pharmaceutical delivery technology.

Notable figures associated with KelSie Biotech include experienced leaders in the biotech and pharmaceutical industries who have driven the company's technological advancements. The company has achieved significant milestones, including the successful implementation of its CAN-BD technology, which has garnered attention for its potential to improve drug efficacy and patient compliance. KelSie Biotech's impact is evident in its contributions to making complex drug formulations more user-friendly and effective, thereby enhancing patient outcomes and setting new standards in the biotech field.

KelSie Biotech - Similar Companies

Nob Hill Therapeutics logo

Nob Hill Therapeutics

Syntis Bio logo

Syntis Bio

syntis.bio

Qnovia logo

Qnovia

qnovia.com

Pure Scientific Technologies logo

Pure Scientific Technologies

Surf Bio logo

Surf Bio

surf.bio

BioSapien logo

BioSapien

biosapien.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Elektrofi logo

Elektrofi

elektrofi.com

Control Delivery Systems logo

Control Delivery Systems

Souvie Biodelivery logo

Souvie Biodelivery

Respira Therapeutics logo

Respira Therapeutics

Kinaset Therapeutics logo

Kinaset Therapeutics

kinasettx.com

Ensysce Biosciences logo

Ensysce Biosciences

ensysce.com

BioKier logo

BioKier

biokier.com

TFF Pharmaceuticals logo

TFF Pharmaceuticals

tffpharma.com

KelSie Biotech - Quick Facts

Who are KelSie Biotech's competitors?

Companies similar to KelSie Biotech include Nob Hill Therapeutics, Syntis Bio, Qnovia and Pure Scientific Technologies.

When was KelSie Biotech founded?

KelSie Biotech was founded in 2017.

Where is KelSie Biotech's headquarters located?

KelSie Biotech's headquarters is located in Englewood, CO, US.

When was KelSie Biotech's last funding round?

KelSie Biotech's most recent funding round was for $1.3M (USD) in April 2021.

How much has KelSie Biotech raised to-date?

As of Apr 2, 2021, KelSie Biotech has raised a total of $1.3M (USD).

How many employees does KelSie Biotech have?

KelSie Biotech has 6 employees as of Feb 5, 2024.

KelSie Biotech - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified